MRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNA.
Ontology highlight
ABSTRACT: The CRISPR-Cas13 system has been proposed as an alternative treatment of viral infections. However, for this approach to be adopted as an antiviral, it must be optimized until levels of efficacy rival or exceed the performance of conventional approaches. To take steps toward this goal, we evaluated the influenza viral RNA degradation patterns resulting from the binding and enzymatic activity of mRNA-encoded LbuCas13a and two crRNAs from a prior study, targeting PB2 genomic and messenger RNA. We found that the genome targeting guide has the potential for significantly higher potency than originally detected, because degradation of the genomic RNA is not uniform across the PB2 segment, but it is augmented in proximity to the Cas13 binding site. The PB2 genome targeting guide exhibited high l
SUBMITTER: Chaves LCS
PROVIDER: S-EPMC11253931 | biostudies-literature | 2024 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA